This dual role hypothesis positions GPBP/CERT as a subject of significant therapeutic interest in several fields, including cancer therapy, neurodegenerative diseases such as Alzheimer’s disease, and autoimmunity [9]. The gene discussed is GPBP1; the disease is early-onset autosomal dominant Alzheimer disease.